A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.
from EurekAlert! - Breaking News https://ift.tt/2JLQYGU
via IFTTT
Friday, March 29, 2019
Nanovaccine boosts immunity in sufferers of metabolic syndrome
About Admin -
Author Description here.. Nulla sagittis convallis. Curabitur consequat. Quisque metus enim, venenatis fermentum, mollis in, porta et, nibh. Duis vulputate elit in elit. Mauris dictum libero id justo.